Clinical Practice Guidelines in the Management of Breakthrough Cancer Pain: A Systematic Review using the Appraisal of Guidelines for Research and Evaluation (AGREE II) Instrument

SP60 PDPH in non-obstetric population. A problem or myth? A problem

“…ICC statistical analysis showed high magnitude of agreement between reviewers with a range of (0.790-0.988).Reflecting upon this quality appraisal, it is evident that the quality and methodologic rigor of BTcP guidelines can be improved upon in the future. These findings also elucidate the existing variability/discrepancies among guidelines in diagnostic criteria and management of BTcP ( Suresh et al 2022). Conclusion A comprehensive pain management approach that addresses the various presentations of pain in patients with cancer is required, including appropriate management of breakthrough pain (Caraceni et al 2013).…”

SP59 Breakthrough cancer pain management: recommendations and international guidelines

“…Reflecting upon this quality appraisal, it is evident that the quality and methodologic rigor of BTcP guidelines can be improved upon in the future. These findings also elucidate the existing variability/discrepancies among guidelines in diagnostic criteria and management of BTcP ( Suresh et al 2022). Conclusion A comprehensive pain management approach that addresses the various presentations of pain in patients with cancer is required, including appropriate management of breakthrough pain (Caraceni et al 2013).…”

Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature

“…4,26,138 Conversely, oral immediate-release opioids can be used to treat slow-onset or predictable BTcP. 34,35,139 Furthermore, both TIRF and oral morphine can be prescribed to manage procedural pain, administered according to their onset of action (10-15 and 30 min, respectively). 138,140 In support of this, a Delphi expert management consensus recommended transmucosal fentanyl and oral morphine as the most appropriate drugs for procedural pain, 138 suitable for both outpatients and inpatients, whilst intravenous and subcutaneous morphine was deemed most appropriate for inpatients.…”

“… 4 , 26 , 138 Conversely, oral immediate-release opioids can be used to treat slow-onset or predictable BTcP. 34 , 35 , 139 Furthermore, both TIRF and oral morphine can be prescribed to manage procedural pain, administered according to their onset of action (10–15 and 30 min, respectively). 138 , 140 …”